These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass in adult patients undergoing cardiac surgery. Asada M; Nagata M; Mizuno T; Uchida T; Takahashi H; Makita K; Arai H; Kijima S; Echizen H; Yasuhara M Eur J Clin Pharmacol; 2021 May; 77(5):735-745. PubMed ID: 33211137 [TBL] [Abstract][Full Text] [Related]
14. Tissue and plasma concentrations of antibiotic during cardiac surgery with cardiopulmonary bypass--microdialysis study. Pojar M; Mandak J; Malakova J; Jokesova I Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):139-45. PubMed ID: 18795089 [TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic models for cefuroxime and metronidazole used in combination as prophylactic agents in colorectal surgery: Model-based evaluation of standard dosing regimens. Asín-Prieto E; Soraluce A; Trocóniz IF; Campo Cimarras E; Sáenz de Ugarte Sobrón J; Rodríguez-Gascón A; Isla A Int J Antimicrob Agents; 2015 May; 45(5):504-11. PubMed ID: 25758019 [TBL] [Abstract][Full Text] [Related]
16. Penetration of cefuroxime in subcutaneous tissue during coronary artery bypass grafting surgery. Nascimento JW; Carmona MJ; Strabelli TM; Auler JO; Santos SR J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(31):3960-4. PubMed ID: 19853540 [TBL] [Abstract][Full Text] [Related]
17. Neither moxifloxacin nor cefuroxime produces significant attenuation of inflammatory mediator release in patients exposed to cardiopulmonary bypass: a randomized controlled trial. Wiesner G; Braun SL; Gruber M; Gertler R; Lange R; Tassani P; Martin K J Antimicrob Chemother; 2012 Jan; 67(1):230-3. PubMed ID: 21972268 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic Model for Cefuroxime Dosing during Cardiac Surgery under Cardiopulmonary Bypass. Lanoiselée J; Zufferey PJ; Hodin S; Tamisier N; Gergelé L; Palao JC; Campisi S; Molliex S; Morel J; Delavenne X; Ollier E Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 33020154 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery. Lanckohr C; Horn D; Voeller S; Hempel G; Fobker M; Welp H; Koeck R; Ellger B J Thorac Cardiovasc Surg; 2016 Aug; 152(2):603-10. PubMed ID: 27209020 [TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass to optimize dosing regimens for children undergoing cardiac surgery. De Cock PA; Mulla H; Desmet S; De Somer F; McWhinney BC; Ungerer JP; Moerman A; Commeyne S; Vande Walle J; Francois K; Van Hasselt JG; De Paepe P J Antimicrob Chemother; 2017 Mar; 72(3):791-800. PubMed ID: 27999040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]